Company Data

Inhibitor Therapeutics Inc

Ticker
INTI
Current Price
$0.075 -6.25%
Market Cap
$12.9M
Price Target
Refer to Report
Volume
10.3K
52wk Range
$0.0338 - $0.0899
Advanced Market Data

Overview

Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders. The company’s main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy